Abstract
The ability to silence gene expression is an invaluable tool for elucidating the importance of intracellular signaling proteins which contribute to the effector functions of mast cells and basophils. However, primary mast cells and their terminally differentiated blood counterpart, basophils, pose a difficult challenge for gene silencing approaches given not only their state of maturation and difficulty to transfect but also because their functions are readily altered by cell handling conditions. Here, we describe a method using lipofection which has been successfully employed to silence gene expression using siRNA in human LAD2 mast cells as well as primary human basophils.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Norata GD, Tibolla G, Catapano AL (2013) Gene silencing approaches for the management of dyslipidaemia. Trends Pharmacol Sci 34:198–205
Macrae I, Zhou K, Li F et al (2006) Structural basis for double-stranded RNA processing by Dicer. Science 311:195–198
Sumbayev VV, Nicholas SA, Streatfield CL et al (2009) Involvement of hypoxia-inducible factor-1 in IgE-mediated primary human basophil responses. Eur J Immunol 39:3511–3519
Sumbayev VV, Yasinska IM, Oniku AE et al (2012) Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PLoS One 7:e34259. https://doi.org/10.1371/journal.pone.0034259
Wang Z, Rao DD, Senzer N et al (2011) RNA interference and cancer therapy. Pharm Res 28:2983–2995
Imai E, Isaka Y (2002) Gene electrotransfer: potential for gene therapy of renal diseases. Kidney Int 61:S37–S41
Vilarino N, MacGlashan D Jr (2005) Transient transfection of human peripheral blood basophils. J Immunol Methods 296:11–18
Burke B (2003) Macrophages as novel cellular vehicles for gene therapy. Expert Opin Biol Ther 3:919–924
Sumbayev VV, Yasinska IM, Gibbs BF (2013) Biomedical applications of gold nanoparticles. In: Recent advances in circuits, communications and signal processing. Springer, New York, NY, pp 342–348
Yasinska IM, Calzolai L, Raap U et al (2019) Targeting of basophil and mast cell pro-allergic reactivity using functionalised gold nanoparticles. Front Pharmacol 10:333. https://doi.org/10.3389/fphar.2019.00333
Yasinska IM, Ceccone G, Ojea-Jimenes I et al (2018) Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates. Nanoscale 10:5827–5833
Nicholas SA, Sumbayev VV (2009) The involvement of hypoxia-inducible factor 1 alpha in Toll-like receptor 7/8-mediated inflammatory response. Cell Res 19:973–983
Shatrov VA, Sumbayev VV, Zhou J et al (2003) Oxidized low density lipoprotein triggers HIF-1alpha protein via redox-dependent mechanism. Blood 101:4847–4849
Kirshenbaum AS, Akin C, Wu Y et al (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27:677–682
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sumbayev, V.V., Gibbs, B.F. (2020). Gene Silencing Approaches in Mast Cells and Primary Human Basophils. In: Gibbs, B.F., Falcone, F.H. (eds) Basophils and Mast Cells. Methods in Molecular Biology, vol 2163. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0696-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0696-4_26
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0695-7
Online ISBN: 978-1-0716-0696-4
eBook Packages: Springer Protocols